Intensity Modulated Radiation Therapy, IMRT
Abstract
Radiation therapy has been the important modality in treatment of cancer patients. Initially, radiation oncologists used conventional radiograph or fluoroscopy to set up the radiation treatment field. Radiation field aperture and angle were defined based on the correlation of tumors and bony structures seen on 2D radiograph. Subsequent advances in imaging technology had resulted in improvement in radiotherapy planning. In mid 1980, computer tomography was generally used in diagnostic department and then widely adopted in radiation oncology community. The treatment
planning systems allowed CT image data to be incorporated into radiotherapy treatment plans, heralding 3-D conformal radiation therapy (3D CRT). Based on this 3D volume, radiation oncologists decided the radiation beam configuration (beam energy, beam aperture, gantry angle, wedge and weighting factors) in the computer. This process is called "virtual simulation". The aims of the treatment are to maximize target coverage as well as minimize normal tissue dose.
Although CT and MRI are used in 3D treatment planning system to define gross tumor volume and subclinical volume, there are some limitations of 3D CRT. 3D CRT needs experienced planner. The planners manually adjust beam directions, beam shapes and beam intensities on the basis of their planning experience and "trial and error" to meet the optimal dose distribution. This process is called "forward planning" which works well for tumors with simple shapes. For complex tumor geometies, such as concave tumors and tumors surrounded by sensitive structures, the forward planning method may be limited by the experience of the individual planner and the restricted beam intensity variation inside each beam.
During mid 1990, the advanced in radiological imaging and computer technology have significantly enhanced the development of intensity modulated radiation therapy. IMRT is an advanced method of 3D CRT that utilizes sophisticated computer-controlled radiation beam delivery to improve the conformality of the dose distribution to the shape of the tumor. IMRT also incorporates computerized inverse treatment plan optimization as opposed to the manual optimization techniques of conventional 3D CRT. The planner designs beam angle, beam energy as well as dose volume constraint; the computer optimization determines the intensities of each beam.
This article will introduce the IMRT to the reader. Discussions of the advantage, limitation and clinical use are also provided.
References
Ling CC, Fuks Z. Conformal radiation treatment: A critical appraisal. Eur J Cancer 1995; 31A(5): 799-803
Scheidhauer K, Scharl A, Pietrzyk U, Wagner R, Gohring UJ, Schomacker K, et al. Qualitative [18F]FDG positron emission tomography in primary breast cancer: Clinical relevance and practicability. Eur I Nucl Med 1996 June; 23(6): 618-623
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxy- glucose. Eur J Nucl Med 1996 Dec; 23(2): 1641-1674
Mac Manus MP, Hicks RJ, Ball DL, Kalff V, Mathews JP, Salminen E, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001 Aug; 92(4): 886-95.
Munley MT, Marks LB, Scarfone C, Sibley GS, Patz. EF Jr, Turkington TG, et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer 19999 Feb; 23(2): 105-14.
Vanuytsel LJ, Vansteenkiste IF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, et al. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000 Jun; 55(3): 317-24.
Chapman JD, Schneider RF, Urbain JL, Hanks GE. Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation. Semin Radiat Oncol 2001 Jan; 11(1): 47-57.
Kurhanewicz I, Vigneron DB, Nelson SJ, Hricak H, MacDonald IM, Konety B, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 1995 Mar; 45(3): 459-66.
Scheidler J, Hnicak H, Vigneron DB, Yu KK, Solov DL, Huang LR, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging- clinicopathologic study. Radiology 19999 Nov; 213(2): 473-80.
Verbey LJ. Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systems. Semin Radiat Oncol 199999 Jan; 9(1): 78-98.
International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. Report 50.Washington (DC): International Commission on Radiation Units and Measurements; 1993.
International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). Report 62. Bethesda (MD): International Commission on Radiation Units and Measurements; 199999.
Suzuki M, Nakamatsu K, Kanamori S, Okumra M, Uchiyama T, Akai F, et al. Feasibibility study of the simultancous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy (IMRT). Jpn J Clin Oncol 2003 Jun; 33(6): 271-7.
Wu Q, Mohan R, Morris M, Lauve A, Schmidi-Ullich R.Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I: dosimetric results. Int J Radiat Oncol Biol Phys 2003 Jun; 56(2): 573-85.
Butler EB, Teh BS, Grant WH 3rd, Uhl BM, Kuppersmith RB, Chiu JK, et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999 Aug; 45(1): 21-32.
Mackie TR, Kapatoes J, Ruchala K, Lu W, Wu C, Olivera G, et al. Image guidance for precise comformal radiotherapy. Int I Radiat Oncol Biol Phys 2003 May; 56(1): 89-105.
Jackson A, Yorke E. NTCP and TCP for treatment planning. In: Fuks Z, Leibel Ling C, editors. A practical guide to intensity-modulated Radiation therapy. Wisconsin: Medical Physics Pubishing; 2003: p 287- 319.
Litzenberg DW, Moran JM, Fraass BA. Incorporation of realistic delivery limitations into dynamic MLCureatment delivery. Med Phys. 2002 May; 29(5): 810-20.
Sicbers JV, Lauterbach M, Keall PJ, Mohan R. Incorporating multi-leaf collimator leaf sequencing into iterative IMRT optimization. Med Phys. 2002 Jun; 29(6): 952-9.
Shepard DM, Earl MA, Li XA, Naqvi S, Yu C. Direct aperture optimization: a turnkey solution for step-and-and- shoot IMRT. Med Phys. 2002 Jun; 29(6): 1007-18.
Xia P, Verhey LJ. Mulileaf collimator leaf sequencing algorithm for intensity modulated beams with multiple static segments. Med Phys. 1998 Aug; 25(8): 1424-34.
Meyer RR. Gunawordena A, D Souza W, et al. Leaf Sequencing via difference Metrices reduces aperture number and beam-on time in IMRT [Abstract]. Int J Radiat Oncol Biol Phys 2003; 57: S267-S268
Kamath S, Sahni S, Li J, Palta J, Ranka S. Leaf sequencing algorithms for segmented mulileaf collimation. Phys Med Biol. 2003 Feb; 48(3): 307-24.
Bortfeld T, Schlegel W. Optimization of beamorientations in radiation therapy: Some theoretical Considerations. Phys Med Biol. 1993 Feb; 38(2): 291-304.
Stein J, Mohan R, Wang XH, Bortfeld T, Wu Q. Preiser K, et al. Number and orientations of beams in intensity-modulated radiation treatments. Med Phys. 1997 Feb; 24(2): 149-60.
Das S, Cullip T, Tracton G, Chang S, Marks L, Anscher M, et al. Beam orientation selection for intensity- modulated radiation therapy based on target equivalent uniform dose maximization. Int I Radiat Oncol Biol Phys. 2003 Jan; 55(1): 215-24.
Pugachev A, Xing L. Incorporating prior knowledgeinto beam orientation optimization in IMRT. Int J Radiat Oncol Biol Phys. 2002 Dec; 54(5): 1565-74.
Lindsay KA, Wheldon EG, Dechan C, Wheldon TE. Radiation carcinogenesis modelling for risk of treatment- related second tumours following radiotherapy. Br J Radiol. 2001 Jun;74(882): 529-36.
Lillicrap SC, Morgan HM, Shakeshaft JT. X-ray leakage during radiotherapy. Br J Radiol 2000] u u 1 : 73(871): 793-4.
Williams PO, Hounsell AR. X-ray leakage considerations for IMRT: Br J Radiol 2001 Jan; 74(877): 98-100.
Mutic S, Low DA, Klein EE, Dempsey JF, Purdy JA. Room shielding for intensity-modulated radiation therapy treatment facilities. Int I Radiat Oncol Biol Phys 2001 May 1; 50(1): 239-46.
Dong L, McGary J, Bellezza D, et al. Whole body dose from Peacock-based IMRT treatment. [Abstract 2158] Proccedings of ASTRO 4274 Annual Meeting. Int J Radiat Oncol Biol Phys 2000 Oct; 48: 342
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์ ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
